Status:

WITHDRAWN

12 Weeks of Hemodialysis With Medium Cut-Off Filter Compared to Hemodiafiltration With Standard High-flux Filter.

Lead Sponsor:

Region Skane

Collaborating Sponsors:

Lund University

Conditions:

Chronic Kidney Diseases

Uremia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The medium cut-off dialysis (MCO) membrane has been developed to improve middle molecule removal compared to standard high-flux dialysis filters. The aim of this study is to compare levels of middle ...

Eligibility Criteria

Inclusion

  • Ongoing HDF treatment (\>3 months)
  • Oliguric
  • Albumin ≥ 30
  • CRP \<15
  • No acute myocardial infarction within 3 months.
  • Swedish or english speaking.

Exclusion

  • \- Not able to understand the study information.

Key Trial Info

Start Date :

February 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2019

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT03416192

Start Date

February 1 2019

End Date

December 1 2019

Last Update

April 15 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

12 Weeks of Hemodialysis With Medium Cut-Off Filter Compared to Hemodiafiltration With Standard High-flux Filter. | DecenTrialz